Estrella Immunopharma, Inc.
Recent Filings
All 240 filings →| Form | Description | Date |
|---|---|---|
| 10-K | ANNUAL REPORT | Mar 18, 2026 |
| 424B3 | PROSPECTUS | Feb 13, 2026 |
| EFFECT | — | Jan 23, 2026 |
| S-1/A | REGISTRATION STATEMENT | Jan 22, 2026 |
| S-1/A | REGISTRATION STATEMENT | Jan 16, 2026 |
| 8-K | CURREN REPORT | Jan 13, 2026 |
| 8-K | CURRENT REPORT | Jan 6, 2026 |
| 424B5 | PROSPECTUS SUPPLEMENT | Jan 6, 2026 |
| S-1 | REGISTRATION STATEMENT | Dec 22, 2025 |
| 8-K | CURRENT REPORT | Dec 4, 2025 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Li Jianwei | Co-Chief Executive Officer | Purchase | 141,970 @ $314,700.00 | 1,253,730 | Mar 4, 2022 |